Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP759329.RAUW7lBksL6KerpqPlLq5ooke6W9bYA-gx7lRUaZGl4iw130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP759329.RAUW7lBksL6KerpqPlLq5ooke6W9bYA-gx7lRUaZGl4iw130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP759329.RAUW7lBksL6KerpqPlLq5ooke6W9bYA-gx7lRUaZGl4iw130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP759329.RAUW7lBksL6KerpqPlLq5ooke6W9bYA-gx7lRUaZGl4iw130_provenance.
- befree-2016 importedOn "2016-02-19" NP759329.RAUW7lBksL6KerpqPlLq5ooke6W9bYA-gx7lRUaZGl4iw130_provenance.
- NP759329.RAUW7lBksL6KerpqPlLq5ooke6W9bYA-gx7lRUaZGl4iw130_assertion wasGeneratedBy ECO_0000203 NP759329.RAUW7lBksL6KerpqPlLq5ooke6W9bYA-gx7lRUaZGl4iw130_provenance.
- NP759329.RAUW7lBksL6KerpqPlLq5ooke6W9bYA-gx7lRUaZGl4iw130_assertion wasDerivedFrom befree-2016 NP759329.RAUW7lBksL6KerpqPlLq5ooke6W9bYA-gx7lRUaZGl4iw130_provenance.
- NP759329.RAUW7lBksL6KerpqPlLq5ooke6W9bYA-gx7lRUaZGl4iw130_assertion SIO_000772 19705967 NP759329.RAUW7lBksL6KerpqPlLq5ooke6W9bYA-gx7lRUaZGl4iw130_provenance.
- NP759329.RAUW7lBksL6KerpqPlLq5ooke6W9bYA-gx7lRUaZGl4iw130_assertion evidence source_evidence_literature NP759329.RAUW7lBksL6KerpqPlLq5ooke6W9bYA-gx7lRUaZGl4iw130_provenance.
- NP759329.RAUW7lBksL6KerpqPlLq5ooke6W9bYA-gx7lRUaZGl4iw130_assertion description "[All ptHL expressed CD15, CD30 and LMP-1 of EBV; the B-cell markers BOB-1, Oct2, CD79a and CD20 were more commonly expressed in ptHL versus cHL (100%, 86%, 50% and 38% in ptHL compared to 6%, 14%, 10% and 33% in cHL, respectively); all ptHL expressed phosphoinositide 3-kinase (PI3K) versus 81% of cHL; 2/6 (33%) ptHL displayed gains at 9p24 that were similar to cHL (32%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP759329.RAUW7lBksL6KerpqPlLq5ooke6W9bYA-gx7lRUaZGl4iw130_provenance.